Search by Drug Name or NDC

    NDC 46122-0383-22 Loratadine and Pseudoephedrine 10; 240 mg/1; mg/1 Details

    Loratadine and Pseudoephedrine 10; 240 mg/1; mg/1

    Loratadine and Pseudoephedrine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by AMERISOURCE BERGEN. The primary component is LORATADINE; PSEUDOEPHEDRINE SULFATE.

    Product Information

    NDC 46122-0383
    Product ID 46122-383_39ace1fb-0f76-4ff6-8846-e6316ee972e5
    Associated GPIs 43993002597520
    GCN Sequence Number 027622
    GCN Sequence Number Description loratadine/pseudoephedrine TAB ER 24H 10MG-240MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63577
    HICL Sequence Number 006605
    HICL Sequence Number Description LORATADINE/PSEUDOEPHEDRINE SULFATE
    Brand/Generic Generic
    Proprietary Name Loratadine and Pseudoephedrine
    Proprietary Name Suffix n/a
    Non-Proprietary Name loratadine and pseudoephedrine
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 10; 240
    Active Ingredient Units mg/1; mg/1
    Substance Name LORATADINE; PSEUDOEPHEDRINE SULFATE
    Labeler Name AMERISOURCE BERGEN
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076557
    Listing Certified Through 2024-12-31

    Package

    NDC 46122-0383-22 (46122038322)

    NDC Package Code 46122-383-22
    Billing NDC 46122038322
    Package 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46122-383-22)
    Marketing Start Date 2017-08-02
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.57422
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ALLERGY-CONGES RELF ER TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 96635cb0-8c78-4c3a-8294-2804ff26f90a Details

    Revised: 6/2021